课题基金 / 基金详情

项目摘要

项目成果

KEITH A. REIMANN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):非人灵长类动物(NHPs)继续作为强大的动物模型,用于探索传染性和非传染性疾病的发病机制,以及用于测试无法在小动物模型中进行评估的新疗法和疫苗。在过去的十年中,美国国立卫生研究院资助的研究项目中使用国家卫生服务提供者的数量增加了50%。然而,在缺乏现成的转基因或基因敲除灵长类动物的情况下,NHP模型的效用往往受到能够在体内调节特定免疫功能的试剂的可用性的限制。在之前的资助期内,这笔拨款建立了NIH非人类灵长类动物试剂资源,这是一个开发和分发基于抗体的试剂的项目,用于消耗体内特定淋巴细胞亚群或靶向体内特定免疫功能。在过去的三年中,该项目已经开发出了产生和生产具有降低免疫原性和改善药代动力学的重组恒河猴单克隆抗体的方法。在此期间,我们分发了近200克抗体试剂,支持48个NIH拨款或代表8个NIH研究所或中心的校内项目,以及11个非NIH资助的项目。此外,通过这笔拨款开发的技术也被NIAID试剂合同所利用,该合同进一步支持使用NHP模型的研究人员。随着对这些独特试剂的需求不断增长,蛋白质工程和表达的新方法也不断涌现,这将使我们能够开发出更专注于细胞亚群靶向的工程抗体,定义效应函数,并使用更有效的表达方法生产它们。为了在多学科科学项目中继续支持NHP模型,我们将:开发“下一代”工程化抗体,用于靶向和消耗nhp2中的主要淋巴细胞亚群。设计抗体Fc区域来调节效应函数3。生成全恒河单克隆抗体,探索恒河IgG 4的多样性。为狒狒、非洲绿猴和狨猴制备IgG表达载体,使其能够生产用于这些其他NHP物种的重组抗体。继续生产和分发这些试剂给使用NHP模型的调查人员
英文摘要
DESCRIPTION (provided by applicant): Nonhuman primates (NHPs) continue to serve as powerful animal models for exploring the pathogenesis of infectious and noninfectious diseases, and for testing of new therapies and vaccines that cannot be evaluated in small animal models. Over the past decade, the number of NIH-funded research projects employing NHPs has increased by 50%. However, in the absence of readily available transgenic or gene knock-out primates, the utility of the NHP models is often limited by the availability of reagents capable of in vivo modulation of specific immune functions. In the preceding funding periods, this grant established the NIH Nonhuman Primate Reagent Resource, a program for developing and distributing antibody-based reagents that deplete specific lymphocyte subpopulations or target specific immune functions in vivo. In the past three years, this program has developed methods for generating and producing rhesus recombinant monoclonal antibodies with reduced immunogenicity and improved pharmacokinetics. Over this period, we distributed nearly 200 grams of antibody reagents supporting 48 NIH grants or intramural programs representing 8 NIH institutes or centers, and 11 non-NIH-funded programs. Furthermore, the technologies developed through this grant are also being utilized by an NIAID reagent contract which further supports investigators who use NHP models. As the need for these unique reagents continues to grow, new methods in protein engineering and expression are also emerging that will allow us to develop engineered antibodies with more focused targeting of cell subpopulations, defined effector function, and to produce them using more efficient expression methods. To continue support of NHP models across multidisciplinary scientific programs we will: 1. Develop "next generation", engineered antibodies for targeting and depleting the major lymphocyte subsets in NHP 2. Engineer antibody Fc regions to modulate effector function 3. Generate fully rhesus monoclonal antibodies and explore the diversity of rhesus IgG 4. Produce IgG expression vectors for baboon, African green monkey and marmoset to enable production of recombinant antibodies for use in these other NHP species 5. Continue to produce and distribute these reagents to investigators using NHP models PUBLIC HEALTH RELEVANCE (provided by applicant): This program will facilitate better utilization of nonhuman primate models by developing and distributing unique research reagents, and support biomedical research across a wide range of scientific disciplines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nonhuman Primate Reagent Resource
NHP reagent resource for AIDS HIV research
NHP reagent resource for immune-mediated and infectious diseases, and transplantation research
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES
  • 批准号:
    8357921
  • 项目类别:
  • 资助金额:
    $6.84万
  • 财政年份:
    2011
  • 负责人:
    KEITH A. REIMANN
  • 依托单位:
海外基金